4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …

Accurate assessment of cardiac function is crucial for the diagnosis of cardiovascular
disease, screening for cardiotoxicity and decisions regarding the clinical management of …

Over the past decade, the use of extracorporeal membrane oxygenation (ECMO) has
increased exponentially, from approximately 30–40 patients per year in the United States 20 …

The European Society of Cardiology (ESC) has published a series of guidelines on heart
failure (HF) over the last 25 years, most recently in 2016. Given the amount of new …

Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …

Background In patients who have chronic heart failure with reduced left ventricular ejection
fraction, severe secondary mitral-valve regurgitation is associated with a poor prognosis …

Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of
morbidity and mortality in patients with established disease. Secular trends in the …

The use of biomarkers as early warning systems in the evaluation of disease risk has
increased markedly in the last decade. Biomarkers are indicators of typical biological …